Page last updated: 2024-08-21

3-hydroxyflavone and Metastase

3-hydroxyflavone has been researched along with Metastase in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chang, HR; Chiou, HL; Hsieh, MH; Hsieh, YH; Lin, CL; Tsai, JP; Yang, SF1
Chou, CH; Hsieh, YH; Lin, CW; Lu, KH; Yang, JS; Yang, SF1
Grzanka, A; Grzanka, D; Hałas-Wiśniewska, M; Klimaszewska-Wiśniewska, A1
Chang, CN; Chang, PC; Chen, JH; Lu, DY; Tsai, CF; Wang, SL; Yeh, WL1
Chen, J; Li, R; Shao, S; Zhang, X; Zhao, Y1
Chien, CS; Huang, JS; Ko, SC; Shen, KH; Shih, YW1
Chao, CH; Chiang, TA; Lee, XY; Liao, YC; Shih, YW1

Other Studies

7 other study(ies) available for 3-hydroxyflavone and Metastase

ArticleYear
Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
    Cells, 2019, 08-21, Volume: 8, Issue:9

    Topics: ADAM Proteins; Antineoplastic Agents; Carcinoma, Renal Cell; Cathepsins; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Proteins; Molecular Structure; Neoplasm Metastasis; Structure-Activity Relationship; Tumor Cells, Cultured

2019
Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 90

    Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Flavonols; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Osteosarcoma; Sp1 Transcription Factor; Urokinase-Type Plasminogen Activator

2021
Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
    International journal of molecular sciences, 2018, Feb-27, Volume: 19, Issue:3

    Topics: A549 Cells; Actins; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flavonoids; Flavonols; Gene Expression Profiling; Humans; Lung Neoplasms; Neoplasm Metastasis; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vimentin

2018
Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018, Volume: 120

    Topics: Cell Line, Tumor; Female; Flavonoids; Flavonols; Heme Oxygenase-1; Humans; Matrix Metalloproteinases; Neoplasm Metastasis; NF-E2-Related Factor 2; Triple Negative Breast Neoplasms

2018
Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells.
    Molecular medicine reports, 2014, Volume: 9, Issue:2

    Topics: Carcinoma; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Flavonoids; Flavonols; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Viral Matrix Proteins

2014
Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells.
    Molecular and cellular biochemistry, 2010, Volume: 333, Issue:1-2

    Topics: Cell Line, Tumor; Down-Regulation; Flavonoids; Flavonols; Humans; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction

2010
Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.
    Journal of agricultural and food chemistry, 2009, Oct-14, Volume: 57, Issue:19

    Topics: Anticarcinogenic Agents; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Enzyme Inhibitors; Flavonoids; Flavonols; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Signal Transduction; Urokinase-Type Plasminogen Activator

2009